Improving the odds for lung cancer patients

[Guest guest]

MEDSCAPE Hematology-Oncology MedPulse®

www.medscape.com/hematology-oncologyhome

MedPulse is a weekly index of key news and features on Medscape's specialty sites compiled by Medscape's Editors.ADVERTISEMENT

Register now at www.oncology-education.com or call 1-

for a free CME audio teleconference on 'The Evolving Role of Hormonal

Therapy in Adjuvant Breast Cancer' on Wednesday, October 9th AND again on Thursday, October 10th (available times are noted on www.oncology-education.com ). This program is provided by the University of South Dakota and supported by an unrestricted educational grant from the Pharmacia Corporation. Joanne E. Mortimer, MD, Professor of Medicine, Eastern Virginia Medical School, Norfolk will present. FROM THE EDITORLeading experts recently convened in Wien, Austria, at the 8th Central European Lung Cancer Conference. In their report, Dr. Hepp and Dr. Eberhardt offer an overview of the state of the art from a European and a global perspective.

click here

The soon-to-be-implemented changes in the breast cancer staging system are being reported in the news and in a recently published article. Read in the latest Hematology-Oncology Journal Scan what is being changed and how that will improve care of breast cancer patients.

click here

You will find links to these and many other articles below.

We welcome your comments and suggestions at HemOncEditor@....

For technical concerns, please contact mpmailings@....

Sara ni MD, PhD

Editor, Medscape Hematology-Oncology

ALSO IN THIS ISSUE:NEWSMEMBER NEWSUSER SUPPORT

NEW FEATURES THIS WEEK

Highlights From the 8th Central European Lung Cancer Conference

Lung cancer rates are declining in parts of Europe, particularly in Finland, but more cancers are being diagnosed in many Eastern European countries. Rates are also increasing in women across Europe.Medscape Hematology-Oncology eJournal 5(5) 2002

Treatment of CML: Thoughts After ASCO 2002

Dr. Talpaz discusses the latest advances in targeted treatment of CML as well as new therapeutic options, and proposes a treatment algorithm for CML.Medscape Hematology-Oncology eJournal 5(5) 2002

Hematology-Oncology Journal Scan, October 2002

Revised breast cancer staging system, UFT in the treatment of colorectal cancer, prostate cancer treatment: to wait or not to wait, and moreMedscape Hematology-Oncology 5(2) 2002

Bilateral Primary Endometrioid Adenocarcinoma of the Fallopian Tubes

A 29-year-old woman (with a 10-year-old history of ectopic pregnancy and left partial salpingectomy) with a sudden onset of pain in the right iliac fossaMedscape Hematology-Oncology eJournal 5(5) 2002

September 2002

The first in a series of monthly columns discussing recent Food and Drug Administration approvals. Medscape Pharmacists 3(2) 2002

Supportive Care of Cancer Patients: Hematopoietic Growth Factors

Dr. Ozer summarizes the results obtained in the management of anemia in cancer patients and discusses the ASCO recommendations for the use of G-CSF and GM-CSF.

Exploring Newer Chemotherapeutic and Targeted Biologic Regimens for Patients With Advanced and Metastatic Breast Cancer

As the number of patients presenting with advanced and metastatic breast cancer escalates, the need for novel systemic therapeutic regimens continues to rise. OVARIAN CANCER RESOURCES FOR PATIENTS

Patients and families can learn about ovarian cancer, including

treatment approaches and clinical trials, through the Ovarian Cancer

National Alliance. Featured via the